Solitron Devices, Inc. Announces Fiscal 2027 First Quarter Results
Solitron Devices (OTC Pink: SODI) reported fiscal 2027 first-quarter results. Net sales rose 101% to about $5.44M from $2.70M. Net income was $0.99M, or $0.46/share, versus a $0.34M net loss. Net bookings fell 48% to $1.45M, while backlog rose 28% to $23.34M. The company also said it is exploring strategic alternatives.
How this was made
The 30-second read
Why it matters
The quarter shows strong revenue and backlog momentum, but net bookings fell sharply and the AMRAAM production ramp is not yet approved. The retained investment banker introduces deal optionality without confirmation.
Market read
Traders may reprice the stock on improved quarterly profitability and backlog, while monitoring procurement approval risk and any future disclosure from the strategic alternatives review.
What to watch
Contingent consideration expense tied to the MEI earn-out could distort quarter-to-quarter earnings quality, and the strategic alternatives review does not guarantee a transaction.
Background
Solitron supplies solid-state semiconductor components primarily to military and aerospace customers, with many products custom-made under US government-linked contracts.
Ticker impact
Solitron reports fiscal 2027 Q1 net sales up 101% to about $5.44M, with backlog up 28% to $23.34M and a retained banker for strategic alternatives.
Moderate positive bias, with volatility risk around any future deal/transaction signals and procurement timing.
The article provides fresh quarterly financial datapoints plus a new process step (retained investment banker) and a procurement read-through (Air Force AMRAAM production request), but it is OTC-listed and lacks explicit guidance or a confirmed contract award.
Market effects
Defense electronics and military/aerospace component suppliers may see read-across interest if AMRAAM production ramps are approved.
Limited, company-specific impact given the small-cap/OTC profile.
Low, as the story is tied to US defense procurement and a single supplier’s backlog.
Counterpoint
Backlog growth may be partially offset by weaker net bookings, and the AMRAAM production increase is only a request requiring Congressional approval.
Key entities
- companySolitron Devices, Inc.
OTC Pink-listed defense semiconductor components supplier reporting fiscal 2027 first quarter results and exploring strategic alternatives.
- companyMEI (Micro Engineering Inc.)
Acquired in 2023; MEI earn-out contingent consideration increased due to a large order received after quarter end.
- governmentU.S. Air Force
Reportedly requested an increase in AMRAAM production from 1,200 to 2,400 annually by 2028 in an unfunded priorities list.